Table 6.
Ecuador | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total—by age | Total—by serology* | Primary | Secondary | |||||||||
Child | Adult | p-value | 1o | 2o | p-value | Child | Adult | p-value | Child | Adult | p-value | |
# Dengue illnesses** | 27 | 67 | NA | 42 | 45 | NA | 13 | 29 | 8 | 37 | ||
Asymptomatic | 34.2% | 32.9% | 0.889 | 42.9% | 22.2% | 0.040 | 53.8% | 37.9% | 0.501 | 25.0% | 21.6% | 1.000 |
Hospitalized | 0% | 0% | NA | 0% | 0% | NA | 0% | 0% | NA | |||
Fever | 22.9% | 14.1% | 0.282 | 9.8% | 20.0% | 0.235 | 8.3% | 10.3% | 1.000 | 25.0% | 18.9% | 0.651 |
Headache | 33.3% | 27.8% | 0.660 | 19.5% | 37.8% | 0.095 | 16.7% | 20.7% | 1.000 | 25.0% | 40.5% | 0.690 |
Rhinorrhea | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cough | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Nausea/vomiting | 13.2% | 7.6% | 0.333 | 4.8% | 8.9% | 0.677 | 0.0% | 6.9% | 1.000 | 0.0% | 10.8% | 1.000 |
Drowsiness | 16.7% | 21.5% | 0.623 | 14.6% | 26.7% | 0.195 | 8.3% | 17.2% | 0.651 | 12.5% | 29.7% | 0.419 |
Muscle/joint pain | 11.1% | 34.2% | 0.012 | 31.7% | 33.3% | 1.000 | 25.0% | 34.5% | 0.719 | 12.5% | 37.8% | 0.236 |
Abdominal pain | 13.9% | 22.8% | 0.323 | 17.1% | 26.7% | 0.311 | 8.3% | 20.7% | 0.651 | 25.0% | 27.0% | 1.000 |
Rash | 22.2% | 7.6% | 0.034 | 14.6% | 13.3% | 1.000 | 33.3% | 6.9% | 0.050 | 25.0% | 10.8% | 0.286 |
Diarrhea | 2.8% | 11.4% | 0.168 | 4.9% | 15.6% | 0.161 | 0.0% | 6.9% | 1.000 | 0.0% | 18.9% | 0.321 |
Retroorbital pain | 13.9% | 26.6% | 0.155 | 17.1% | 35.6% | 0.087 | 16.7% | 17.2% | 1.000 | 25.0% | 37.8% | 0.691 |
Bleeding | 0.0% | 1.3% | 1.000 | 2.4% | 0.0% | 0.477 | 0.0% | 3.4% | 1.000 | 0.0% | 0.0% | NA |
Of those with valid serological results (i.e., either primary or secondary DENV infection).
Among all those with confirmed DENV infection (i.e., whether symptomatic or asymptomatic).
P-values < 0.05 indicate statistically significant comparisons, applying Mantel-Haenszel chi-squared testing.
NA indicates not applicable.